H91.09
Ototoxic hearing loss, unspecified ear
Clinical Classification Guidelines
Medical Intelligence & Overview
Ototoxic hearing loss refers to hearing impairment caused by substances that damage the ear or nerves related to hearing. This condition affects the inner ear or the auditory nerve and can result from exposure to certain medications or chemicals. When the origin of hearing loss is unknown or unspecified, it is categorized under the ICD-10 code H91.09. Recognizing and understanding this condition is vital for affected individuals and healthcare providers to manage symptoms and prevent further damage.
Causes & Symptoms
Clinical Causes: Use of ototoxic medications such as aminoglycoside antibiotics, chemotherapy agents like cisplatin, and certain loop diuretics. Prolonged exposure to high levels of noise which may compound existing ear damage. Chemical exposure to substances like solvents, heavy metals, or environmental toxins. Age-related degeneration that may be exacerbated by ototoxic factors. Underlying genetic predispositions making individuals more susceptible to ear damage from toxins.
Key Symptoms: Gradual or sudden hearing loss, often affecting the high-frequency range. Tinnitus, which is the perception of ringing or buzzing noises in the ear. Difficulty understanding speech, especially in noisy environments. Dizziness or balance problems, which may accompany inner ear damage. A feeling of fullness or pressure in the affected ear.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of ototoxic hearing loss involves a combination of clinical assessments and tests, including hearing evaluations like audiometry. Healthcare providers review patient history to identify exposure to ototoxic substances, and may perform additional tests such as otoacoustic emissions (OAE) or electronystagmography (ENG) to assess inner ear and balance function. Imaging studies might be employed to rule out other causes of hearing impairment. Early detection is essential to prevent further damage and to develop appropriate management plans.
Treatment Protocols: Management typically focuses on preventing further exposure to ototoxic agents and minimizing hearing loss. Interventions may include discontinuing or substituting the offending medication under medical supervision, using hearing aids to improve hearing, and providing counseling or auditory rehabilitation. In some cases, medications may be prescribed to alleviate symptoms like tinnitus, but treatment options are limited once damage has occurred. Regular follow-up and hearing assessments are crucial for monitoring the progression of hearing loss.
Clinical Advice & FAQs
Billing Guidance
Is H91.09 a billable ICD-10 code?
Yes, H91.09 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H91.09?
Clinical documentation must specify the nature of Ototoxic hearing loss, unspecified ear and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
